Edition:
India

Tasly Pharmaceutical Group Co Ltd (600535.SS)

600535.SS on Shanghai Stock Exchange

22.41CNY
15 Nov 2018
Change (% chg)

¥0.10 (+0.45%)
Prev Close
¥22.31
Open
¥22.28
Day's High
¥22.42
Day's Low
¥22.03
Volume
3,373,180
Avg. Vol
7,774,362
52-wk High
¥34.22
52-wk Low
¥18.18

Latest Key Developments (Source: Significant Developments)

Four Chinese Companies Weighing London Market Debut-China Daily
Tuesday, 30 Oct 2018 

Oct 29 (Reuters) - :ZHEJIANG HUAYOU COBALT, SHANGHAI ORIENTAL PEARL GROUP, KANGMEI PHARMACEUTICAL CO, TASLY PHARMACEUTICAL GROUP WEIGHING LONDON MARKET DEBUT-CHINA DAILY.THE FOUR CHINESE COS DISCUSSED WITH RELATED PARTIES POSSIBLE FRAMEWORKS TO RAISE FUNDS IN UK THROUGH GLOBAL DEPOSITARY RECEIPTS - CHINA DAILY.  Full Article

Tasly Pharmaceutical Says 9-Month Net Profit Up 20.2 Percent Y/Y
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>::SAYS 9-MONTH NET PROFIT UP 20.2 PERCENT Y/Y.  Full Article

Mesoblast Ltd Enters Alliance With Tasly Pharmaceutical Group
Tuesday, 17 Jul 2018 

July 17 (Reuters) - Mesoblast Ltd ::ENTERED INTO A STRATEGIC ALLIANCE WITH TASLY PHARMACEUTICAL GROUP.DEAL FOR DEVELOPMENT IN CHINA OF CO'S PRODUCT FOR TREATMENT OR PREVENTION OF CHRONIC HEART FAILURE AND ACUTE MYOCARDIAL INFARCTION.UNDER ALLIANCE, MESOBLAST WILL RECEIVE US$40 MILLION ON CLOSING.  Full Article

Tasly Pharmaceutical Group says change of CFO
Wednesday, 11 Jul 2018 

July 11(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says Li Jinyuan resigned from CFO .Says it appoints Wei Jie as new CFO of the company .  Full Article

Tasly Pharmaceutical Group unit receives permission of two clinical trials granted by China FDA
Monday, 9 Jul 2018 

July 9 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS> ::Says its wholly owned unit received permission of two clinical trial granted by China FDA with respect to TSL-1502 capsule and paclitarel Injection for emulsion dilution which are used to help cancer treatment .  Full Article

Tasly Pharmaceutical Group to pay FY 2017 annual div on June 5
Tuesday, 29 May 2018 

May 29(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS> ::Says it plans to pay FY 2017 dividend to shareholders of record on June 4.The company's shares will be traded ex-right and ex-dividend on June 5 and the dividend will be paid on June 5.  Full Article

Tasly Pharmaceutical Group issues 2018 first tranche medium-term notes worth 1 bln yuan
Monday, 7 May 2018 

May 7(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says it issued 2018 first tranche medium-term notes worth 1 billion yuan, with a term of three years and an interest rate of 5.39 percent .  Full Article

Tasly Pharmaceutical Group elects chairman, appoints general manager and CFO
Tuesday, 17 Apr 2018 

April 17(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says it elects Yan Kaijing as chairman, appoints Zhu Yonghong as general manager and Li Jinyuan as chief financial officer.  Full Article

Tasly Pharmaceutical Says Its Q1 Net Profit Up 16.77 Percent Y/Y
Monday, 16 Apr 2018 

April 16 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>::SAYS ITS Q1 NET PROFIT UP 16.77 PERCENT Y/Y AT 371.5 MILLION YUAN ($59.14 million).  Full Article

Tasly Pharmaceutical Group announces 2017 dividend payment
Tuesday, 27 Mar 2018 

March 27(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says it plans to pay a cash dividend of 4.00 yuan (pre-tax) per 10 shares to shareholders for 2017, and use additional paid-in capital to distribute four new shares for every 10 shares.  Full Article